The Global Private Non-Profit Expenditure on R&D in Medical and Health Sciences showcases significant investment differences among countries, led by Japan ($631.84 million PPP). South Korea and Italy follow with $436.06 million and $390.84 million, respectively. Smaller economies, like Romania and Slovakia, show substantial year-on-year percentage growth at 31.28% and -23.42%, respectively, indicating volatility. Czech Republic experienced one of the most significant increases at 27.02%, whereas Chile and Taiwan experienced downturns. The CAGR highlights sustained trends over the past five years, suggesting a shift towards increased investment in Asian countries, while some European countries experience slower growth or declines.
Future trends to watch include the expansion of R&D investment in emerging markets, particularly in Asian countries, potentially driven by increased demand for innovative medical solutions. Monitoring economic and policy changes in Europe will be necessary due to varied growth trends. Additionally, technology advancements will likely affect investment allocations significantly, making this a critical area for ongoing observation.
Top countries in Private Non-Profit Expenditure on R&D in Medical and Health Sciences by Country
| # | 10 Countries | Million US Dollars PPP = 2015 | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Japan | 631.84 | 2023 | +1.31% | +5.32% | View data |
| 2 | 2 South Korea | 436.06 | 2023 | +4.97% | +15.7% | View data |
| 3 | 3 Italy | 390.84 | 2023 | -0.38% | +4.76% | View data |
| 4 | 4 Canada | 49.29 | 2023 | -3.91% | +2.72% | View data |
| 5 | 5 Spain | 48.45 | 2023 | +2.25% | +3.43% | View data |
| 6 | 6 Finland | 31.58 | 2023 | +4.2% | +3.62% | View data |
| 7 | 7 Russia | 17.42 | 2023 | +6.17% | +26.31% | View data |
| 8 | 8 Portugal | 16.37 | 2023 | +5.23% | +5% | View data |
| 9 | 9 Chile | 12.87 | 2023 | -0.054% | -3.94% | View data |
| 10 | 10 Taiwan | 5.63 | 2023 | -9.78% | -5.14% | View data |
